Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Actually, a phase 1/2 clinical trial of combining ganitumab with Src inhibitor dasatinib in patients with embryonal and alveolar rhabdomyosarcoma is ongoing (Table 1)
The frequency: For maintenance (for example, preventing LPP flares), dosing may be as infrequent as once every few months
It neutralizes these toxins, making them more water-soluble and easier for the body to eliminate through urine or bile
References Richie, J.P., Nichenametla, S., Neidig, W., Calcagnotto, A., Haley, J.S., Schell, T.D., and Muscat, J.E
Start with a lower dose (e.g., 500-1000 mg) and gradually increase if needed, based on your individual requirements and healthcare provider's recommendation
US$ 29.65
US$ 20.01
US$ 21.50
US$ 25.35
US$ 22.57
